Carbogen Amcis Enhances Stability Studies Capacity

Swiss-based Carbogen Amcis, has expanded its service portfolio and capacity for stability studies. In compliance with the latest International Conference on Harmonization (ICH) guidelines, and in response to customer demand, the company has installed new stability chambers at the Hunzenschwil (Neuland), Switzerland operations and offers short-term, long-term, accelerated, intermediate, follow-up and customized tests.

Carbogen Amcis' new fully validated and mapped stability chambers operate at ICH conditions (25°C/60% RH, 30°C/65% RH, and 40°C/75% RH) and at low temperatures (5°C, -20°C and -80°C). With a current shelf storage capacity of about 92 m2, they provide secure and safe storage for API  samples, including highly potent material, employed for in-house stability studies.

"We are facing an increasing customer demand for stability studies, as a stand-alone service or tied to our API development and production efforts," Brian O'Neill, Carbogen Amcis sales manager, said.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read